![Patricia van Dijck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patricia van Dijck is currently the Director-Market Access & Public Affairs at GSK Belux since 2018.
Prior to this, she worked as an Independent Director at Mithra Pharmaceuticals SA from 2021 to 2023, as a Medical Director at Lundbeck SA from 1998 to 2007, and as the Head-Market Access & Public Affairs at Novartis Belux.
She holds a doctorate degree from the Université Catholique de Louvain.
| Unternehmen | Position | Beginn |
|---|---|---|
GSK Belux | Public Communications Contact | 01.01.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
| MITHRA PHARMACEUTICALS S.A. | Vorsitzender | 01.06.2021 |
Novartis Belux | Public Communications Contact | - |
Lundbeck SA
 Lundbeck SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
Mithra Pharmaceuticals SA
 Mithra Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for woman health sector | Health Technology |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck SA
Lundbeck SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Novartis Belux | |
GSK Belux |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
